SCHEMBL944778

SCHEMBL944778

CCCCCCN(CCCCCC)C(=O)CC(=O)N(CCCCCC)CCCCCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.50
CA1 P00915 3/20 0.50
CA9 Q16790 3/20 0.50
CA2 P00918 1/20 0.50
MGLL Q99685 1/20 0.45
KDM5A P29375 4/20 0.44
PHF8 Q9UPP1 3/20 0.44
KDM4C Q9H3R0 3/20 0.44
ZDHHC20 Q5W0Z9 2/20 0.44
ZDHHC2 Q9UIJ5 1/20 0.44
DNM1 Q05193 3/20 0.44
MMP1 P03956 1/20 0.43
MMP2 P08253 1/20 0.43
MMP3 P08254 1/20 0.43
MMP8 P22894 1/20 0.43
EPHX1 P07099 2/20 0.43
CES2 O00748 3/20 0.42
CES1 P23141 3/20 0.42
KDM5C P41229 1/20 0.42
KDM5B Q9UGL1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23748010 1.00 CA12 (0.50) CA12CA1CA9CA2MGLL
SCHEMBL3625206 0.98 CA12 (0.48) CA12CA1CA9CA2MGLL
SCHEMBL7184994 0.92 CA12 (0.44) CA12CA1CA9CA2MGLL
SCHEMBL8373264 0.92 CA12 (0.44) CA12CA1CA9CA2MGLL
SCHEMBL283713 0.90 CA12 (0.56) CA12CA1CA9CA2KDM5A
SCHEMBL11357421 0.89 CA12 (0.45) CA12CA1CA9CA2MGLL
SCHEMBL1128973 0.89 KDM5A (0.49) CA12CA1CA9CA2KDM5A
SCHEMBL5712587 0.87 CA12 (0.44) CA12CA1CA9CA2MGLL
SCHEMBL10341598 0.87 CA12 (0.44) CA12CA1CA9CA2MGLL
SCHEMBL11315449 0.87 CA12 (0.44) CA12CA1CA9CA2MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025068560-A1 COMPOSITE MATERIAL USEFUL FOR EXTRACTING PALLADIUM, PROCESS FOR PREPARING SAME AND USES THEREOF COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2025-04-03 WO claimed
EP-3662089-B1 METHOD FOR SEPARATING PALLADIUM FROM OTHER METAL ELEMENTS PRESENT IN AN AQUEOUS NITRIC PHASE USING SPECIFIC MALONAMIDES AS EXTRACTANTS COMMISSARIAT ENERGIE ATOMIQUE (FR) 2021-08-18 EP claimed
US-7879306-B2 Dispersion and separation of nanostructured carbon in organic solvents ROCHESTER INSTITUTE OF TECHNOLOGY (US) 2011-02-01 US claimed
US-20080008643-A1 Dispersion and separation of nanostructured carbon in organic solvents ROCHESTER INSTITUTE OF TECHNOLOGY (US) 2008-01-10 US claimed
WO-2025068560-A1 COMPOSITE MATERIAL USEFUL FOR EXTRACTING PALLADIUM, PROCESS FOR PREPARING SAME AND USES THEREOF COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2025-04-03 WO disclosed
US-20240240059-A1 EPOXY RESIN MODIFIER, EPOXY RESIN COMPOSITION CONTAINING SAME, ADHESIVE COMPOSED OF EPOXY RESIN COMPOSITION, AND RESIN CURED PRODUCT OBTAINED BY CURING EPOXY RESIN COMPOSITION OTSUKA CHEMICAL CO., LTD. (JP) 2024-07-18 US disclosed
US-20230395856-A1 ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING THE SAME SK INNOVATION CO., LTD. (KR) 2023-12-07 US disclosed
EP-4065739-A1 METHOD FOR RECOVERING GOLD AND/OR ONE OR MORE PLATINOIDS PRESENT IN AN ACIDIC AQUEOUS PHASE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2022-10-05 EP disclosed
EP-3662089-B1 METHOD FOR SEPARATING PALLADIUM FROM OTHER METAL ELEMENTS PRESENT IN AN AQUEOUS NITRIC PHASE USING SPECIFIC MALONAMIDES AS EXTRACTANTS COMMISSARIAT ENERGIE ATOMIQUE (FR) 2021-08-18 EP disclosed
EP-3662089-A1 METHOD FOR SEPARATING PALLADIUM FROM OTHER METAL ELEMENTS PRESENT IN AN AQUEOUS NITRIC PHASE USING SPECIFIC MALONAMIDES AS EXTRACTANTS Commissariat à l'énergie atomique et aux énergies alternatives (FR) 2020-06-10 EP disclosed
EP-1996602-B1 NOVEL LACTOSAMINE DERIVATIVES GLYCOM APS (DK) 2011-02-16 EP disclosed
US-7879306-B2 Dispersion and separation of nanostructured carbon in organic solvents ROCHESTER INSTITUTE OF TECHNOLOGY (US) 2011-02-01 US disclosed
US-7875257-B2 Dispersion and separation of nanostructured carbon in organic solvents ROCHESTER INSTITUTE OF TECHNOLOGY (US) 2011-01-25 US disclosed
US-7875257-B2 Dispersion and separation of nanostructured carbon in organic solvents ROCHESTER INSTITUTE OF TECHNOLOGY (US) 2011-01-25 US disclosed
US-20090320571-A1 A dispersion of nanostructured carbon in an organic solvent, comprising the diamide compound 2-R1,7-R2-perhydrocopyrine(2,7-naphthyridine) where R1 and R2 are independently selected from C1-C6 alkyl and phenyl; mobilizing; purity determination; analysis of electrical, optical and mechanical properties ROCHESTER INSTITUTE OF TECHNOLOGY (US) 2009-12-31 US disclosed
US-20090320571-A1 A dispersion of nanostructured carbon in an organic solvent, comprising the diamide compound 2-R1,7-R2-perhydrocopyrine(2,7-naphthyridine) where R1 and R2 are independently selected from C1-C6 alkyl and phenyl; mobilizing; purity determination; analysis of electrical, optical and mechanical properties ROCHESTER INSTITUTE OF TECHNOLOGY (US) 2009-12-31 US disclosed
US-20090320571-A1 A dispersion of nanostructured carbon in an organic solvent, comprising the diamide compound 2-R1,7-R2-perhydrocopyrine(2,7-naphthyridine) where R1 and R2 are independently selected from C1-C6 alkyl and phenyl; mobilizing; purity determination; analysis of electrical, optical and mechanical properties ROCHESTER INSTITUTE OF TECHNOLOGY (US) 2009-12-31 US disclosed
US-20080008643-A1 Dispersion and separation of nanostructured carbon in organic solvents ROCHESTER INSTITUTE OF TECHNOLOGY (US) 2008-01-10 US disclosed
US-20080008643-A1 Dispersion and separation of nanostructured carbon in organic solvents ROCHESTER INSTITUTE OF TECHNOLOGY (US) 2008-01-10 US disclosed
US-20080008643-A1 Dispersion and separation of nanostructured carbon in organic solvents ROCHESTER INSTITUTE OF TECHNOLOGY (US) 2008-01-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230395856-A1 ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING THE SAME LDHB, SLC9B2, CLCN2 CA12 191/4885CA1 330/4885CA9 41/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.